CLOs on the Move


 
AveXis, now a Novartis Company, is a clinical-stage gene therapy company relentlessly focused on bringing gene therapy out of the lab and into the clinical setting for patients and families devastated by rare and life-threatening neurological genetic d...
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million
  • www.avexis.com
  • 2275, Half Day Road
    Bannockburn, IL USA 60015
  • Phone: 972.725.7797

Executives

Name Title Contact Details

Similar Companies

Bioforward

Bioforward is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Myrexis

Myrexis, Inc. is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Eyenovia

Eyenovia is a clinical stage, biopharmaceutical company transforming the delivery of therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. Eyenovia`s breakthrough piezo-dispersion and microdosing technology enable a portfolio of first-in-class, next-generation, micro-therapeutics for the eye designed to reduce ocular and systemic toxicity and improve the risk-benefit profile of both new and existing therapeutics.

Progenics

Progenics is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Gen9

Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. The Gen9 technology allows for the lowest-cost and highest-quality DNA constructs commercially available. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 is powering the synthetic biology revolution from our headquarters in Cambridge, Mass